Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

921 recalls · Class II, newest first

Class II · Moderate risk

Phenol

Lack of Assurance of Sterility

Terminated Sterility / contamination Edge Pharma, LLC NDC 05446-1476-05 D-0413-2022
Class II · Moderate risk

Mvasi

Lack of Assurance of Sterility

Terminated Sterility / contamination Edge Pharma, LLC NDC 05446-1661-13 D-0412-2022
Class II · Moderate risk

Extra Strength Headache

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0391-2022
Class II · Moderate risk

Medique Pain-Off

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0390-2022
Class II · Moderate risk

Physicians CARE Extra Strength PAIN RELIEVER

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0389-2022
Class II · Moderate risk

B-Complex

Lack of Processing Controls

Terminated cGMP deviation Valgene Incorporated dba Cape Drugs D-0284-2022

Recalls by year